Business Context and Reporting Period
This Form 6-K filing by Visionsys AI Inc covers the month of July 2026. The registrant is a foreign private issuer headquartered in Sanhe City, Hebei Province, China. The filing discloses a material corporate event: a private placement of securities.
Key Financial Metrics
The filing does not provide standard financial statements, revenue, profit, cash flow, margins, or debt levels. The only financial data disclosed relates to the proposed private placement transaction:
- Shares Issued: 125,000,000,000 Class A ordinary shares.
- Price Per Share: $0.000734.
- Aggregate Purchase Price: Approximately $91,750,000.
- Payment Method: Fiat money or cryptocurrencies, at the Company's discretion.
Material Changes
The primary material change is the execution of a Securities Purchase Agreement on July 10, 2026. This transaction represents a significant potential increase in the company's share count and capital base, contingent upon closing. No prior period financial comparisons are available in this document.
Guidance, Outlook, and Risks
Transaction Status: The private placement is expected to close in the third quarter of 2026. The transaction is subject to customary representations, warranties, and covenants.
Risks and Contingencies: The filing notes that the summary of terms is qualified by the full Purchase Agreement (Exhibit 99.1). The ability to accept cryptocurrency as payment introduces potential volatility and regulatory considerations not detailed in the summary text. The filing does not provide specific management commentary on future operational outlook or risks beyond the transaction terms.
Investor Verification Checklist
- Verify the final closing date and confirmation of funds received in Q3 2026.
- Review the full Securities Purchase Agreement (Exhibit 99.1) for specific covenants and conditions precedent.
- Assess the impact of issuing 125 billion shares on existing shareholder dilution.
- Confirm the proportion of the purchase price paid in fiat versus cryptocurrency and the associated accounting treatment.
- Check for any subsequent filings regarding the use of proceeds from this capital raise.